Biological monitoring of exposure to sevoflurane in operating room personnel by the measurement of hexafluoroisopropanol and fluoride in urine

Biomarkers

Volumn 5, Issue 2, 2000, Pages 141-151

  Haufroid, Vincent ^a   Cardinal, Sophie ^a   Licot, Catherine ^a   Villalpando, Marie Laure ^a   Van Obbergh, Luc ^a   Clippe, Andre ^a   Lison, Dominique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Biological monitoring; Cytochrome P4502E1; Occupational exposure; Sevoflurane

Indexed keywords

2 PROPANOL; FLUORIDE; SEVOFLURANE;

AIR ANALYSIS; ANESTHESIA; ARTICLE; BIOLOGICAL MONITORING; DRUG EXPOSURE; DRUG URINE LEVEL; HUMAN; OCCUPATIONAL EXPOSURE;

EID: 0034064070     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/135475000230451     Document Type: Article

References (20)

1. BRODSKY, J. B. and COHEN, E. N. 1985, Health experiences of operating room personnel. Anesthesiology, 63, 461-463.
2. HALL, J. E., HENDERSON, K. A., OLDHAM, T. A., PUGH, S. and HARMER, M. 1997, Environmental monitoring during gaseous induction with sevoflurane. British Journal of Anaesthesia, 79, 342-345.
3. HAUFROID, V., CLIPPE, A., KNOOPS, B., BERNARD, A. and LISON, D. 1998, Genotyping in urine: an interesting tool for epidemiological studies. Clinical Chemistry, 44, 2210-2211.
4. HAYASHI, S. I., WATANABE, J. and KAWAJIRI, K. 1991, Genetic polymorphism in the 5′-flanking region change the transcriptional regulation of the human cytochrome P450IIE1 gene. Journal of Biochemistry, 110, 559-565.
5. HOERAUF, K. H., KOLLER, C., TAEGER, K. and HOBBHAHN, J. 1997, Occupational exposure to sevoflurane and nitrous oxide in operating room personnel. International Archives of Occupational and Environmental Health, 69, 134-138.
6. KATO, S., SHIELDS, P. G., CAPORASO, N. E., HOOVER, R. N., TRUMP, B. F., SUGIMURA, H., WESTON, A. and HARRIS, C. C. 1992, Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Research, 52, 6712-6715.
7. KHARASCH, E. D., KAROL, M. D., LANNI, C. and SAWCHUK, R. 1995a, Clinical sevoflurane metabolism and disposition. I. Sevoflurane and metabolite pharmacokinetics. Anesthesiology, 82, 1369-1378.
8. KHARASCH, E. D., ARMSTRONG, A. S., GUNN, K., ARTRU, A., COX, K. and KAROL, M. D. 1995b, Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P4502E1 in fluoride and hexafluoroisopropanol formation. Anesthesiology, 82, 1379-1388.
9. KIM, R. B., O'SHEA, D. O. and WILKINSON, G. R. 1995, Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clinical Pharmacology and Therapeutics, 57, 645-654.
10. LIEBER, C. S. 1997, Cytochrome P-4502E1: Its physiological and pathological role. Physiological Reviews, 77, 517-544.
11. MAZZE, R. I. and LECKY, J. H. 1985, The health of operating room personnel. Anethesiology, 62, 226-228.
12. MCBRIDE, O. W., UMENO, M., GELBOIN, H. V. and GONZALEZ, F. J. 1987, A Taq I polymorphism in the human P450IIE1 gene on chromosome 10 (CYP2E). Nucleic Acids Research, 15, 10071.
13. MORGAN, S. E., FRINK, E. J. and GANDOLFI, A. J. 1994, A simplified gas chromatographic method for quantifying the sevoflurane metabolite hexafluoroisopropanol. Anesthesiology, 80, 201-205.
14. NARAYANAN, S. and APPLETON, H. D. 1980, Creatinine: a review. Clinical Chemistry, 26, 1119-1126.
15. NIOSH, 1977, Criteria for a recommended standard: occupational exposure to waste anaesthetic gases and vapors (DHEW publication no. 77-140) (Cincinnati: US Department of Health, Education and Welfare).
16. PERSSON, I., JOHANSSON, I., BERGLING, H., DAHL, M. L., SEIDEGARD, J., RYLANDER, R., RANNUG, A., HOGBERG, J. and SUNDBERG, M. I. 1993, Genetic polymorphism of CYP2E1 in a Swedish population. Relationship to the occurrence of lung cancer. FEBS Letters, 319, 207-211.
17. RANNUG, A., ALEXANDRIE, A.-K., PERSSON, I. and INGELMAN-SUNDBERG, M. 1995, Genetic-polymorphism of cytochromes P450 1A1, 2D6 and 2E1: Regulation and toxicological significance. Journal of Occupational and Environmental Medicine, 37, 25-36.
18. STEPHENS, E. A., TAYLOR, J. A., KAPLAN, N., YANG, C. H., HSIEH, L. L., LUCIER, G. W. and BELL, D. A. 1994, Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics, 4, 185-192.
19. UEMATSU, F., KIKUCHI, H., OHMACHI, T., SAGAMI, I., MOTOMIYA, M., KAMATAKI, T., KOMORI, M. and WATANABE, M. 1991, Two common RFLPs of the human CYP2E gene. Nucleic Acids Research, 19, 2803.
20. WATANABE, J., HAYASHI, S. I., NAKACHI, K., IMAI, K., SUDA, Y., SEKINE, T. and KAWAJIRI, K. 1990, PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Research, 18, 7194.